In this report, we sought to determine whether DCLK1 protein can be detected in the bloodstream and if its levels in archived serum samples could be quantitatively assessed in pancreatic cancer patients and in PDAC mouse model. Here, DCLK1 is linked to pancreatic neoplasm.